Fighting Shigella by Blocking Its Disease-Causing Toxin

J Med Chem. 2021 May 13;64(9):6059-6069. doi: 10.1021/acs.jmedchem.1c00152. Epub 2021 Apr 28.

Abstract

Shiga toxin is an AB5 toxin produced by Shigella species, while related toxins are produced by Shiga toxin-producing Escherichia coli (STEC). Infection by Shigella can lead to bloody diarrhea followed by the often fatal hemolytic uremic syndrome (HUS). In the present paper, we aimed for a simple and effective toxin inhibitor by comparing three classes of carbohydrate-based inhibitors: glycodendrimers, glycopolymers, and oligosaccharides. We observed a clear enhancement in potency for multivalent inhibitors, with the divalent and tetravalent compounds inhibiting in the millimolar and micromolar range, respectively. However, the polymeric inhibitor based on galabiose was the most potent in the series exhibiting nanomolar inhibition. Alginate and chitosan oligosaccharides also inhibit Shiga toxin and may be used as a prophylactic drug during shigella outbreaks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbohydrates / chemistry*
  • Carbohydrates / pharmacology*
  • Drug Discovery*
  • Shiga Toxin / antagonists & inhibitors*

Substances

  • Carbohydrates
  • Shiga Toxin